{"gene":"GPAT4","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":2008,"finding":"AGPAT6/GPAT4 is a microsomal glycerol-3-phosphate acyltransferase (GPAT), not an AGPAT; purified AGPAT6 protein possesses GPAT activity but not AGPAT activity, and overexpression in HEK293 cells increases LPA and PA levels; the enzyme is N-ethylmaleimide (NEM)-sensitive and localizes to the endoplasmic reticulum.","method":"In vitro GPAT activity assay with purified protein, substrate specificity studies, siRNA knockdown, 13C-oleic acid labeling with mass spectrometry, subcellular fractionation/localization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — purified protein activity assay plus multiple orthogonal methods (isotope labeling, MS, siRNA KD, localization) in a single study","pmids":["18238778"],"is_preprint":false},{"year":2008,"finding":"GPAT4 (encoded by Agpat6) catalyzes the NEM-sensitive GPAT step (first step in de novo TAG synthesis); Agpat6-/- mouse liver and brown adipose tissue show 65% reduction in NEM-sensitive GPAT activity but normal AGPAT activity; overexpression of Agpat6 in Cos-7 cells increases NEM-sensitive GPAT activity; LPA/PA/DAG intermediates from GPAT4 reside in different cellular pools than those initiated by GPAT1.","method":"Enzyme activity assays in knockout mouse tissues and Cos-7 overexpression cells, [14C]oleate radiolabeling, genetic loss-of-function","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1–2 — enzymatic assays in both KO tissues and overexpression cells, replicated across two independent labs (PMID 18238778 and 18192653)","pmids":["18192653"],"is_preprint":false},{"year":2006,"finding":"AGPAT6/GPAT4 localizes exclusively to the endoplasmic reticulum in mammalian cells and is required for lipid droplet formation and triacylglycerol/diacylglycerol production in mammary epithelial cells; Agpat6-/- mice show dramatically reduced lipid droplets and milk fat.","method":"Gene-trap knockout mouse model, histology, northern blot, subcellular localization studies, milk lipid analysis","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype (lipid droplet loss, milk fat depletion) plus localization experiment","pmids":["16449762"],"is_preprint":false},{"year":2010,"finding":"GPAT4 is phosphorylated at Ser and Thr residues in response to insulin, leading to increased GPAT activity in a wortmannin-sensitive manner, linking insulin signaling to microsomal glycerolipid biosynthesis.","method":"Insulin stimulation of cells overexpressing GPAT4, phosphorylation assay, wortmannin inhibition, shRNA knockdown, GPAT activity assay","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 — functional phosphorylation with pathway inhibitor, single lab","pmids":["20181984"],"is_preprint":false},{"year":2010,"finding":"GPAT4 knockdown in 3T3-L1 adipocytes does not significantly decrease GPAT activity, lipid accumulation, or adipogenic marker expression during differentiation, whereas GPAT3 knockdown does; GPAT4 plays a modest role in adipogenesis compared to GPAT3.","method":"shRNA-mediated knockdown, lipid accumulation assay, adipogenic marker expression (qPCR), GPAT activity assay","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 — clean KD with defined cellular readouts, single lab","pmids":["20181984"],"is_preprint":false},{"year":2013,"finding":"GPAT1, but not GPAT4, incorporates de novo synthesized fatty acids into TAG and diverts them from β-oxidation; GPAT4-deficient hepatocytes incorporate a similar amount of exogenous fatty acid into TAG as controls but cannot channel newly synthesized fatty acids into TAG.","method":"Primary mouse hepatocytes from Gpat1-/- and Gpat4-/- mice, de novo fatty acid synthesis labeling, exogenous [14C]fatty acid incorporation, acylcarnitine measurements, in vivo fasting-refeeding protocol","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with multiple quantitative metabolic readouts in vitro and in vivo, clean epistatic distinction from GPAT1","pmids":["23908354"],"is_preprint":false},{"year":2015,"finding":"GPAT4 comprises ~65% of total GPAT activity in brown adipose tissue and limits oxidation of exogenous fatty acids; Gpat4-/- brown adipocytes incorporate 33% less fatty acid into TAG and 46% more into β-oxidation, with the increase due solely to exogenous fatty acid oxidation.","method":"Gpat4-/- mouse model, GPAT activity assay in BAT, metabolic rate measurement, differentiated primary brown adipocytes, fatty acid oxidation and incorporation assays, PPARα/UCP1 gene expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple orthogonal metabolic readouts in vivo and in vitro","pmids":["25918168"],"is_preprint":false},{"year":2019,"finding":"CHP1 (calcineurin B homologous protein 1) binds and activates GPAT4; N-myristoylation of CHP1 is required for this interaction and for GPAT4 activity, making CHP1 a major regulator of ER glycerolipid synthesis.","method":"CRISPR-based genetic screens, unbiased lipidomics, protein-protein interaction (CHP1-GPAT4 binding), N-myristoylation mutagenesis, fatty acid incorporation assays in mammalian cells and invertebrates","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1–2 — CRISPR screen + binding assay + mutagenesis of critical interface + lipidomics, replicated in multiple organisms","pmids":["30846317"],"is_preprint":false},{"year":2020,"finding":"GPAT4 synthesizes saturated lysophosphatidic acids (e.g., 1-stearoyl-LPA) at the contact site between omegasomes and the MAM (mitochondria-associated membrane); accumulation of these saturated LPAs causes abnormal omegasome formation, blocks autophagosome maturation, and inhibits autophagic flux in vascular smooth muscle cells.","method":"SCD knockout VSMCs, lipid metabolite analysis, immunofluorescence/co-localization of GPAT4 with omegasome markers, autophagic flux assays","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2–3 — localization with functional consequence (autophagic flux inhibition), single lab, mechanistic inference from lipid species accumulation","pmids":["32408172"],"is_preprint":false},{"year":2022,"finding":"PPARγ transcriptionally regulates AGPAT6/GPAT4 expression via an RXRα binding site at -96 bp of the AGPAT6 promoter; AGPAT6/GPAT4 generates phosphatidic acid (PA) in response to acetate stimulation, which activates mTORC1 signaling and promotes milk fat synthesis in dairy cow mammary epithelial cells.","method":"siRNA knockdown, luciferase reporter assay with promoter deletions/mutations, PA rescue experiment, phosphorylation assay of mTORC1 pathway components, intracellular TAG measurement","journal":"The Journal of dairy research","confidence":"Medium","confidence_rationale":"Tier 2 — promoter reporter assay + PA rescue + signaling readouts, single lab","pmids":["36398416"],"is_preprint":false},{"year":2025,"finding":"GPAT4 deficiency in endocardial cells induces ER stress, enhances ER-mitochondria (MAM) communications, and causes mitochondrial DNA (mtDNA) escape, which triggers the cGAS-STING pathway and type-I interferon response, leading to heart development defects; abolishment of cGAS-STING-interferon signaling rescues cardiac defects in Gpat4 knockout mice.","method":"Global and tissue-specific Gpat4 knockout mice, ER stress markers, ER-mito communication assays, mtDNA escape measurement, cGAS-STING pathway analysis, genetic rescue (cGAS-STING pathway ablation)","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — clean tissue-specific KO with defined molecular pathway (ER stress → MAM → mtDNA → cGAS-STING → IFN) plus genetic epistasis rescue","pmids":["40199910"],"is_preprint":false},{"year":2024,"finding":"GPAT4 traffics between the ER membrane and the lipid droplet (LD) surface via seipin-containing ER-LD bridges; upon reaching the LD surface, GPAT4 becomes nano-confined in nanoscale membrane domains, a mechanism driving selective protein accumulation on LDs.","method":"MINFLUX and HILO single-molecule tracking, machine learning trajectory analysis, live-cell imaging of GPAT4 diffusion dynamics","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — single-molecule tracking with mechanistic dissection of targeting motif, preprint not yet peer-reviewed","pmids":["bio_10.1101_2024.08.27.610018"],"is_preprint":true},{"year":2025,"finding":"FXR transcriptionally inhibits GPAT4 expression; loss of FXR activity (or SNS treatment) increases GPAT4 levels and promotes hepatic lipid droplet accumulation via enhanced glycerophospholipid biosynthesis, while FXR activation reduces GPAT4-dependent lipid deposition in MAFLD models.","method":"siRNA knockdown, dual-luciferase reporter assay, western blot, mouse HFD model, in vitro hepatocyte model","journal":"Chinese medicine","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assay confirms transcriptional regulation, supported by KD and in vivo data, single lab","pmids":["41530783"],"is_preprint":false},{"year":2025,"finding":"CPT2 inhibition in colorectal cancer cells drives long-chain fatty acid flux into GPAT4-mediated glycerophospholipid biosynthesis, increasing phosphatidylcholine and phosphatidylethanolamine; these glycerophospholipids promote autophagosome maturation and selective autophagy (lipophagy), accelerating tumor progression.","method":"CPT2 knockdown, metabolite analysis, transcriptomics, in vitro and in vivo proliferation assays","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2–3 — metabolite analysis and transcriptomics link GPAT4 to autophagosome biology, pathway placement by epistasis, single lab","pmids":["41107458"],"is_preprint":false}],"current_model":"GPAT4 (encoded by AGPAT6) is an NEM-sensitive, endoplasmic reticulum-localized glycerol-3-phosphate acyltransferase that catalyzes the first and rate-limiting step of de novo glycerolipid synthesis, generating lysophosphatidic acid from glycerol-3-phosphate and acyl-CoA; its activity is activated by the N-myristoylated binding partner CHP1, upregulated by insulin-stimulated phosphorylation (PI3K-dependent), and transcriptionally regulated by PPARγ and FXR; GPAT4 directs exogenous (but not de novo synthesized) fatty acids into triacylglycerol, limits excess fatty acid oxidation in brown adipose tissue, produces saturated LPAs that regulate autophagy, and maintains ER homeostasis in endocardial cells—with ER stress upon its loss triggering mtDNA escape and cGAS-STING-driven cardiac developmental defects; at the cellular level, GPAT4 traffics from the ER to lipid droplets via seipin-containing ER-LD bridges and becomes nano-confined in LD surface membrane domains."},"narrative":{"teleology":[{"year":2006,"claim":"Establishing that AGPAT6/GPAT4 localizes to the ER and is essential for lipid droplet formation and triacylglycerol production resolved its basic cellular function and tissue requirement, as Agpat6-/- mice showed dramatic loss of milk fat and lipid droplets in mammary epithelium.","evidence":"Gene-trap knockout mouse, histology, subcellular localization, milk lipid analysis","pmids":["16449762"],"confidence":"High","gaps":["Enzymatic activity of the protein had not been directly measured","Whether the enzyme acted as a GPAT or AGPAT was unresolved","Mechanism of lipid droplet loss was unclear"]},{"year":2008,"claim":"Demonstrating that purified AGPAT6 possesses GPAT but not AGPAT activity reclassified the enzyme as GPAT4 and established it as the major NEM-sensitive microsomal GPAT, resolving a long-standing misannotation.","evidence":"Purified protein GPAT activity assay, substrate specificity studies, 13C-oleic acid labeling/MS, KO tissue enzyme assays in two independent labs","pmids":["18238778","18192653"],"confidence":"High","gaps":["Post-translational regulation of GPAT4 activity was unknown","Substrate selectivity among different acyl-CoA chains was not fully defined","How GPAT4-generated lipid intermediates differed from GPAT1-derived pools remained unclear"]},{"year":2010,"claim":"Discovery that insulin stimulates GPAT4 phosphorylation in a PI3K-dependent manner, increasing its activity, connected glycerolipid biosynthesis to anabolic hormone signaling, while showing GPAT4 plays a modest role in adipocyte differentiation relative to GPAT3.","evidence":"Insulin stimulation of GPAT4-overexpressing cells, wortmannin inhibition, shRNA knockdown in 3T3-L1 adipocytes","pmids":["20181984"],"confidence":"Medium","gaps":["Specific phosphorylation sites mediating activation were not mapped","Kinase(s) directly phosphorylating GPAT4 were not identified","Physiological consequence of insulin-driven GPAT4 activation in vivo was not tested"]},{"year":2013,"claim":"Establishing that GPAT4 channels exogenous—but not de novo synthesized—fatty acids into TAG clarified the division of labor between GPAT1 and GPAT4, showing they access distinct fatty acid pools.","evidence":"Primary hepatocytes from Gpat1-/- and Gpat4-/- mice, de novo FA synthesis labeling, exogenous [14C]FA incorporation","pmids":["23908354"],"confidence":"High","gaps":["Molecular basis for selective access to exogenous vs. de novo fatty acid pools was unknown","Whether this selectivity applies in non-hepatic tissues was not tested"]},{"year":2015,"claim":"Quantifying GPAT4 as ~65% of total GPAT activity in brown adipose tissue and showing that its loss redirects exogenous fatty acids from TAG synthesis into β-oxidation defined GPAT4 as a metabolic gatekeeper in thermogenic fat.","evidence":"Gpat4-/- mice, GPAT activity in BAT, differentiated primary brown adipocytes, fatty acid oxidation/incorporation assays","pmids":["25918168"],"confidence":"High","gaps":["Whether increased β-oxidation in GPAT4-null BAT affects whole-body thermogenesis was not conclusively shown","Compensatory changes in GPAT1 or GPAT3 expression were not fully addressed"]},{"year":2019,"claim":"Identification of N-myristoylated CHP1 as a direct binding partner and activator of GPAT4 revealed the first protein-level regulatory mechanism for microsomal GPAT activity.","evidence":"CRISPR genetic screens, lipidomics, CHP1-GPAT4 binding assay, N-myristoylation mutagenesis in mammalian cells and invertebrates","pmids":["30846317"],"confidence":"High","gaps":["Structural basis for CHP1-GPAT4 interaction was not resolved","Whether CHP1 regulation is modulated by calcium or other signals was not determined","Tissue-specific importance of CHP1-GPAT4 axis was unexplored"]},{"year":2020,"claim":"Showing that GPAT4-generated saturated LPAs accumulate at ER-mitochondria contact sites and block autophagosome maturation linked GPAT4 lipid products to autophagy regulation beyond simple TAG storage.","evidence":"SCD-knockout VSMCs, lipid metabolite analysis, GPAT4 co-localization with omegasome markers, autophagic flux assays","pmids":["32408172"],"confidence":"Medium","gaps":["Direct manipulation of GPAT4 (rather than SCD) to confirm the autophagy phenotype was not performed","Whether saturated LPA effects on autophagy are generalizable beyond VSMCs was untested","Physical mechanism by which saturated LPAs block omegasome resolution was not defined"]},{"year":2022,"claim":"Identifying PPARγ/RXRα as a transcriptional activator of GPAT4 and linking GPAT4-produced PA to mTORC1 activation established a signaling axis from nuclear receptor to lipid intermediate to nutrient sensing in mammary epithelial cells.","evidence":"Promoter-luciferase reporter assay with deletions/mutations, PA rescue, mTORC1 phosphorylation readouts in dairy cow mammary epithelial cells","pmids":["36398416"],"confidence":"Medium","gaps":["Whether PPARγ regulation of GPAT4 occurs in non-mammary tissues was not tested","ChIP confirmation of PPARγ occupancy at the endogenous promoter was lacking","Whether PA-mediated mTORC1 activation is GPAT4-specific or shared with other GPATs was unclear"]},{"year":2025,"claim":"Demonstrating that GPAT4 loss in endocardial cells triggers ER stress, mitochondrial DNA escape via enhanced ER-mitochondria contacts, and a cGAS-STING-interferon inflammatory cascade causing cardiac defects—rescued by cGAS-STING ablation—established GPAT4 as an ER homeostasis factor whose absence activates innate immune pathways during development.","evidence":"Global and endocardial-specific Gpat4 KO mice, ER stress markers, MAM communication assays, mtDNA escape measurement, genetic epistasis rescue via cGAS-STING ablation","pmids":["40199910"],"confidence":"High","gaps":["Whether ER stress from GPAT4 loss is due to lipid composition change or protein misfolding was not distinguished","Whether the cGAS-STING pathway is activated in other GPAT4-deficient tissues was not examined","Human genetic evidence linking GPAT4 mutations to congenital heart disease is lacking"]},{"year":2025,"claim":"Identifying FXR as a transcriptional repressor of GPAT4 and showing that GPAT4 upregulation drives hepatic lipid droplet accumulation in MAFLD models established a second nuclear receptor axis controlling GPAT4 expression with disease relevance.","evidence":"siRNA knockdown, dual-luciferase reporter assay, HFD mouse model, in vitro hepatocyte model","pmids":["41530783"],"confidence":"Medium","gaps":["Direct FXR binding site on the GPAT4 promoter was not mapped by ChIP","Whether FXR-GPAT4 axis operates independently of PPARγ regulation was not addressed"]},{"year":null,"claim":"Key unresolved questions include the structural basis of GPAT4 catalysis and CHP1 activation, the mechanism by which GPAT4 selectively accesses exogenous versus de novo fatty acid pools, whether GPAT4 mutations cause human disease, and the in vivo significance of GPAT4 nano-confinement on lipid droplet surfaces.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of GPAT4","No human Mendelian disease linked to GPAT4 mutations","Molecular basis for selective fatty acid pool access is unknown","Functional consequence of LD surface nano-confinement is untested in vivo"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,6,7]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,5,6]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,2,7,10]},{"term_id":"GO:0005811","term_label":"lipid droplet","supporting_discovery_ids":[2,11]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,2,5,6,9]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[8,13]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,9,10]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10]}],"complexes":[],"partners":["CHP1","BSCL2"],"other_free_text":[]},"mechanistic_narrative":"GPAT4 is an NEM-sensitive, endoplasmic reticulum-localized glycerol-3-phosphate acyltransferase that catalyzes the first committed step of de novo glycerolipid synthesis, generating lysophosphatidic acid (LPA) from glycerol-3-phosphate and acyl-CoA, thereby channeling exogenous fatty acids into triacylglycerol and away from β-oxidation [PMID:18238778, PMID:18192653, PMID:25918168]. Its enzymatic activity is stimulated by the N-myristoylated binding partner CHP1, enhanced by insulin-dependent phosphorylation via PI3K, and transcriptionally controlled by PPARγ and FXR [PMID:30846317, PMID:20181984, PMID:36398416, PMID:41530783]. GPAT4 is required for lipid droplet biogenesis and milk fat synthesis in mammary epithelium, and in brown adipose tissue it accounts for ~65% of total GPAT activity, limiting exogenous fatty acid oxidation [PMID:16449762, PMID:25918168]. Loss of GPAT4 in endocardial cells triggers ER stress, mitochondrial DNA escape, and cGAS-STING-dependent type-I interferon signaling that causes cardiac developmental defects—a phenotype rescued by ablation of the cGAS-STING pathway [PMID:40199910]."},"prefetch_data":{"uniprot":{"accession":"Q86UL3","full_name":"Glycerol-3-phosphate acyltransferase 4","aliases":["1-acylglycerol-3-phosphate O-acyltransferase 6","1-AGP acyltransferase 6","1-AGPAT 6","Acyl-CoA:glycerol-3-phosphate acyltransferase 4","Lysophosphatidic acid acyltransferase zeta","LPAAT-zeta","Testis spermatogenesis apoptosis-related protein 7","TSARG7"],"length_aa":456,"mass_kda":52.1,"function":"Converts glycerol-3-phosphate to 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid or LPA) by incorporating an acyl moiety at the sn-1 position of the glycerol backbone (PubMed:18238778). Active against both saturated and unsaturated long-chain fatty acyl-CoAs (PubMed:18238778). Protects cells against lipotoxicity (PubMed:30846318)","subcellular_location":"Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/Q86UL3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GPAT4","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000158669","cell_line_id":"CID000327","localizations":[{"compartment":"er","grade":3},{"compartment":"vesicles","grade":1}],"interactors":[{"gene":"AGPAT6","stoichiometry":10.0},{"gene":"CHP1","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/target/CID000327","total_profiled":1310},"omim":[{"mim_id":"611396","title":"ADIPOGENIN; ADIG","url":"https://www.omim.org/entry/611396"},{"mim_id":"606158","title":"BSCL2 GENE; BSCL2","url":"https://www.omim.org/entry/606158"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GPAT4"},"hgnc":{"alias_symbol":["DKFZp586M1819","LPAAT-zeta","TSARG7"],"prev_symbol":["AGPAT6"]},"alphafold":{"accession":"Q86UL3","domains":[{"cath_id":"-","chopping":"165-427","consensus_level":"high","plddt":92.8426,"start":165,"end":427}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86UL3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q86UL3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q86UL3-F1-predicted_aligned_error_v6.png","plddt_mean":85.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GPAT4","jax_strain_url":"https://www.jax.org/strain/search?query=GPAT4"},"sequence":{"accession":"Q86UL3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q86UL3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q86UL3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86UL3"}},"corpus_meta":[{"pmid":"18492828","id":"PMC_18492828","title":"ACSL1, AGPAT6, FABP3, LPIN1, and SLC27A6 are the most abundant isoforms in bovine mammary tissue and their expression is affected by stage of lactation.","date":"2008","source":"The Journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/18492828","citation_count":182,"is_preprint":false},{"pmid":"18238778","id":"PMC_18238778","title":"AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18238778","citation_count":116,"is_preprint":false},{"pmid":"18192653","id":"PMC_18192653","title":"Identification of a novel sn-glycerol-3-phosphate acyltransferase isoform, GPAT4, as the enzyme deficient in Agpat6-/- mice.","date":"2008","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/18192653","citation_count":104,"is_preprint":false},{"pmid":"16449762","id":"PMC_16449762","title":"Agpat6--a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium.","date":"2006","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/16449762","citation_count":101,"is_preprint":false},{"pmid":"20181984","id":"PMC_20181984","title":"GPAT3 and GPAT4 are regulated by insulin-stimulated phosphorylation and play distinct roles in adipogenesis.","date":"2010","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/20181984","citation_count":90,"is_preprint":false},{"pmid":"30846317","id":"PMC_30846317","title":"CHP1 Regulates Compartmentalized Glycerolipid Synthesis by Activating GPAT4.","date":"2019","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30846317","citation_count":84,"is_preprint":false},{"pmid":"23908354","id":"PMC_23908354","title":"Glycerol-3-phosphate acyltransferase (GPAT)-1, but not GPAT4, incorporates newly synthesized fatty acids into triacylglycerol and diminishes fatty acid oxidation.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23908354","citation_count":69,"is_preprint":false},{"pmid":"12938015","id":"PMC_12938015","title":"Cloning and identification of the human LPAAT-zeta gene, a novel member of the lysophosphatidic acid acyltransferase family.","date":"2003","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12938015","citation_count":49,"is_preprint":false},{"pmid":"24465687","id":"PMC_24465687","title":"Expression variants of the lipogenic AGPAT6 gene affect diverse milk composition phenotypes in Bos taurus.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24465687","citation_count":48,"is_preprint":false},{"pmid":"25918168","id":"PMC_25918168","title":"Glycerol-3-phosphate Acyltransferase Isoform-4 (GPAT4) Limits Oxidation of Exogenous Fatty Acids in Brown Adipocytes.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25918168","citation_count":26,"is_preprint":false},{"pmid":"32408172","id":"PMC_32408172","title":"GPAT4-Generated Saturated LPAs Induce Lipotoxicity through Inhibition of Autophagy by Abnormal Formation of Omegasomes.","date":"2020","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/32408172","citation_count":21,"is_preprint":false},{"pmid":"38739804","id":"PMC_38739804","title":"The GPAT4/6/8 clade functions in Arabidopsis root suberization nonredundantly with the GPAT5/7 clade required for suberin lamellae.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38739804","citation_count":13,"is_preprint":false},{"pmid":"38036221","id":"PMC_38036221","title":"Function identification of Arabidopsis GPAT4 and GPAT8 in the biosynthesis of suberin and cuticular wax.","date":"2023","source":"Plant science : an international journal of experimental plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/38036221","citation_count":12,"is_preprint":false},{"pmid":"22095600","id":"PMC_22095600","title":"AGPAT6 polymorphism and its association with milk traits of dairy goats.","date":"2011","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/22095600","citation_count":12,"is_preprint":false},{"pmid":"35649414","id":"PMC_35649414","title":"Functional roles for AGPAT6 in milk fat synthesis of buffalo mammary epithelial cells.","date":"2022","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/35649414","citation_count":9,"is_preprint":false},{"pmid":"36398416","id":"PMC_36398416","title":"PPARγ-AGPAT6 signaling mediates acetate-induced mTORC1 activation and milk fat synthesis in mammary epithelial cells of dairy cows.","date":"2022","source":"The Journal of dairy research","url":"https://pubmed.ncbi.nlm.nih.gov/36398416","citation_count":6,"is_preprint":false},{"pmid":"40199910","id":"PMC_40199910","title":"GPAT4 sustains endoplasmic reticulum homeostasis in endocardial cells and safeguards heart development.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40199910","citation_count":4,"is_preprint":false},{"pmid":"41107458","id":"PMC_41107458","title":"CPT2 inhibition enhances selective autophagy and proliferation in colorectal cancer via GPAT4-dependent glycerophospholipid biosynthesis.","date":"2025","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/41107458","citation_count":3,"is_preprint":false},{"pmid":"35635030","id":"PMC_35635030","title":"Development of TaqMan PCR assay for genotyping SNP rs211250281 of the bovine agpat6 gene.","date":"2022","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/35635030","citation_count":3,"is_preprint":false},{"pmid":"32671121","id":"PMC_32671121","title":"Detection of Single-Nucleotide Polymorphism in AGPAT6 Gene, Associated with Milk Fat Content, using Tetra-Primer ARMS PCR-Based Assay, in Karan Fries Breeding Bulls.","date":"2019","source":"Iranian journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/32671121","citation_count":3,"is_preprint":false},{"pmid":"24156295","id":"PMC_24156295","title":"Studies of association of AGPAT6 variants with type 2 diabetes and related metabolic phenotypes in 12,068 Danes.","date":"2013","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24156295","citation_count":2,"is_preprint":false},{"pmid":"16625827","id":"PMC_16625827","title":"Molecular cloning and preliminary function study of a novel human gene, TSARG7, related to spermatogenesis.","date":"2006","source":"Yi chuan xue bao = Acta genetica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/16625827","citation_count":1,"is_preprint":false},{"pmid":"37906284","id":"PMC_37906284","title":"Functional analysis of the GPAT4 gene mutation predicted to affect splicing.","date":"2023","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/37906284","citation_count":0,"is_preprint":false},{"pmid":"41530783","id":"PMC_41530783","title":"Si-Ni-San improves the deposition of lipid droplets in MAFLD through modulating the FXR-GPAT4 axis.","date":"2026","source":"Chinese medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41530783","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.25.650743","title":"<i>GPAT2</i> plays a role in the root cap cuticle formation of Arabidopsis that is not redundant to <i>GPAT4</i> and <i>GPAT8</i>","date":"2025-04-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.25.650743","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.27.610018","title":"Organelle bridges and nanodomain partitioning govern targeting of membrane-embedded proteins to lipid droplets","date":"2024-08-28","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.27.610018","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14556,"output_tokens":3619,"usd":0.048976},"stage2":{"model":"claude-opus-4-6","input_tokens":7053,"output_tokens":3083,"usd":0.16851},"total_usd":0.217486,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"AGPAT6/GPAT4 is a microsomal glycerol-3-phosphate acyltransferase (GPAT), not an AGPAT; purified AGPAT6 protein possesses GPAT activity but not AGPAT activity, and overexpression in HEK293 cells increases LPA and PA levels; the enzyme is N-ethylmaleimide (NEM)-sensitive and localizes to the endoplasmic reticulum.\",\n      \"method\": \"In vitro GPAT activity assay with purified protein, substrate specificity studies, siRNA knockdown, 13C-oleic acid labeling with mass spectrometry, subcellular fractionation/localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — purified protein activity assay plus multiple orthogonal methods (isotope labeling, MS, siRNA KD, localization) in a single study\",\n      \"pmids\": [\"18238778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GPAT4 (encoded by Agpat6) catalyzes the NEM-sensitive GPAT step (first step in de novo TAG synthesis); Agpat6-/- mouse liver and brown adipose tissue show 65% reduction in NEM-sensitive GPAT activity but normal AGPAT activity; overexpression of Agpat6 in Cos-7 cells increases NEM-sensitive GPAT activity; LPA/PA/DAG intermediates from GPAT4 reside in different cellular pools than those initiated by GPAT1.\",\n      \"method\": \"Enzyme activity assays in knockout mouse tissues and Cos-7 overexpression cells, [14C]oleate radiolabeling, genetic loss-of-function\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — enzymatic assays in both KO tissues and overexpression cells, replicated across two independent labs (PMID 18238778 and 18192653)\",\n      \"pmids\": [\"18192653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"AGPAT6/GPAT4 localizes exclusively to the endoplasmic reticulum in mammalian cells and is required for lipid droplet formation and triacylglycerol/diacylglycerol production in mammary epithelial cells; Agpat6-/- mice show dramatically reduced lipid droplets and milk fat.\",\n      \"method\": \"Gene-trap knockout mouse model, histology, northern blot, subcellular localization studies, milk lipid analysis\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype (lipid droplet loss, milk fat depletion) plus localization experiment\",\n      \"pmids\": [\"16449762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GPAT4 is phosphorylated at Ser and Thr residues in response to insulin, leading to increased GPAT activity in a wortmannin-sensitive manner, linking insulin signaling to microsomal glycerolipid biosynthesis.\",\n      \"method\": \"Insulin stimulation of cells overexpressing GPAT4, phosphorylation assay, wortmannin inhibition, shRNA knockdown, GPAT activity assay\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional phosphorylation with pathway inhibitor, single lab\",\n      \"pmids\": [\"20181984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GPAT4 knockdown in 3T3-L1 adipocytes does not significantly decrease GPAT activity, lipid accumulation, or adipogenic marker expression during differentiation, whereas GPAT3 knockdown does; GPAT4 plays a modest role in adipogenesis compared to GPAT3.\",\n      \"method\": \"shRNA-mediated knockdown, lipid accumulation assay, adipogenic marker expression (qPCR), GPAT activity assay\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with defined cellular readouts, single lab\",\n      \"pmids\": [\"20181984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GPAT1, but not GPAT4, incorporates de novo synthesized fatty acids into TAG and diverts them from β-oxidation; GPAT4-deficient hepatocytes incorporate a similar amount of exogenous fatty acid into TAG as controls but cannot channel newly synthesized fatty acids into TAG.\",\n      \"method\": \"Primary mouse hepatocytes from Gpat1-/- and Gpat4-/- mice, de novo fatty acid synthesis labeling, exogenous [14C]fatty acid incorporation, acylcarnitine measurements, in vivo fasting-refeeding protocol\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple quantitative metabolic readouts in vitro and in vivo, clean epistatic distinction from GPAT1\",\n      \"pmids\": [\"23908354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GPAT4 comprises ~65% of total GPAT activity in brown adipose tissue and limits oxidation of exogenous fatty acids; Gpat4-/- brown adipocytes incorporate 33% less fatty acid into TAG and 46% more into β-oxidation, with the increase due solely to exogenous fatty acid oxidation.\",\n      \"method\": \"Gpat4-/- mouse model, GPAT activity assay in BAT, metabolic rate measurement, differentiated primary brown adipocytes, fatty acid oxidation and incorporation assays, PPARα/UCP1 gene expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple orthogonal metabolic readouts in vivo and in vitro\",\n      \"pmids\": [\"25918168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CHP1 (calcineurin B homologous protein 1) binds and activates GPAT4; N-myristoylation of CHP1 is required for this interaction and for GPAT4 activity, making CHP1 a major regulator of ER glycerolipid synthesis.\",\n      \"method\": \"CRISPR-based genetic screens, unbiased lipidomics, protein-protein interaction (CHP1-GPAT4 binding), N-myristoylation mutagenesis, fatty acid incorporation assays in mammalian cells and invertebrates\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — CRISPR screen + binding assay + mutagenesis of critical interface + lipidomics, replicated in multiple organisms\",\n      \"pmids\": [\"30846317\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GPAT4 synthesizes saturated lysophosphatidic acids (e.g., 1-stearoyl-LPA) at the contact site between omegasomes and the MAM (mitochondria-associated membrane); accumulation of these saturated LPAs causes abnormal omegasome formation, blocks autophagosome maturation, and inhibits autophagic flux in vascular smooth muscle cells.\",\n      \"method\": \"SCD knockout VSMCs, lipid metabolite analysis, immunofluorescence/co-localization of GPAT4 with omegasome markers, autophagic flux assays\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — localization with functional consequence (autophagic flux inhibition), single lab, mechanistic inference from lipid species accumulation\",\n      \"pmids\": [\"32408172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PPARγ transcriptionally regulates AGPAT6/GPAT4 expression via an RXRα binding site at -96 bp of the AGPAT6 promoter; AGPAT6/GPAT4 generates phosphatidic acid (PA) in response to acetate stimulation, which activates mTORC1 signaling and promotes milk fat synthesis in dairy cow mammary epithelial cells.\",\n      \"method\": \"siRNA knockdown, luciferase reporter assay with promoter deletions/mutations, PA rescue experiment, phosphorylation assay of mTORC1 pathway components, intracellular TAG measurement\",\n      \"journal\": \"The Journal of dairy research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter reporter assay + PA rescue + signaling readouts, single lab\",\n      \"pmids\": [\"36398416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GPAT4 deficiency in endocardial cells induces ER stress, enhances ER-mitochondria (MAM) communications, and causes mitochondrial DNA (mtDNA) escape, which triggers the cGAS-STING pathway and type-I interferon response, leading to heart development defects; abolishment of cGAS-STING-interferon signaling rescues cardiac defects in Gpat4 knockout mice.\",\n      \"method\": \"Global and tissue-specific Gpat4 knockout mice, ER stress markers, ER-mito communication assays, mtDNA escape measurement, cGAS-STING pathway analysis, genetic rescue (cGAS-STING pathway ablation)\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean tissue-specific KO with defined molecular pathway (ER stress → MAM → mtDNA → cGAS-STING → IFN) plus genetic epistasis rescue\",\n      \"pmids\": [\"40199910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GPAT4 traffics between the ER membrane and the lipid droplet (LD) surface via seipin-containing ER-LD bridges; upon reaching the LD surface, GPAT4 becomes nano-confined in nanoscale membrane domains, a mechanism driving selective protein accumulation on LDs.\",\n      \"method\": \"MINFLUX and HILO single-molecule tracking, machine learning trajectory analysis, live-cell imaging of GPAT4 diffusion dynamics\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — single-molecule tracking with mechanistic dissection of targeting motif, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2024.08.27.610018\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"FXR transcriptionally inhibits GPAT4 expression; loss of FXR activity (or SNS treatment) increases GPAT4 levels and promotes hepatic lipid droplet accumulation via enhanced glycerophospholipid biosynthesis, while FXR activation reduces GPAT4-dependent lipid deposition in MAFLD models.\",\n      \"method\": \"siRNA knockdown, dual-luciferase reporter assay, western blot, mouse HFD model, in vitro hepatocyte model\",\n      \"journal\": \"Chinese medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assay confirms transcriptional regulation, supported by KD and in vivo data, single lab\",\n      \"pmids\": [\"41530783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CPT2 inhibition in colorectal cancer cells drives long-chain fatty acid flux into GPAT4-mediated glycerophospholipid biosynthesis, increasing phosphatidylcholine and phosphatidylethanolamine; these glycerophospholipids promote autophagosome maturation and selective autophagy (lipophagy), accelerating tumor progression.\",\n      \"method\": \"CPT2 knockdown, metabolite analysis, transcriptomics, in vitro and in vivo proliferation assays\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — metabolite analysis and transcriptomics link GPAT4 to autophagosome biology, pathway placement by epistasis, single lab\",\n      \"pmids\": [\"41107458\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GPAT4 (encoded by AGPAT6) is an NEM-sensitive, endoplasmic reticulum-localized glycerol-3-phosphate acyltransferase that catalyzes the first and rate-limiting step of de novo glycerolipid synthesis, generating lysophosphatidic acid from glycerol-3-phosphate and acyl-CoA; its activity is activated by the N-myristoylated binding partner CHP1, upregulated by insulin-stimulated phosphorylation (PI3K-dependent), and transcriptionally regulated by PPARγ and FXR; GPAT4 directs exogenous (but not de novo synthesized) fatty acids into triacylglycerol, limits excess fatty acid oxidation in brown adipose tissue, produces saturated LPAs that regulate autophagy, and maintains ER homeostasis in endocardial cells—with ER stress upon its loss triggering mtDNA escape and cGAS-STING-driven cardiac developmental defects; at the cellular level, GPAT4 traffics from the ER to lipid droplets via seipin-containing ER-LD bridges and becomes nano-confined in LD surface membrane domains.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GPAT4 is an NEM-sensitive, endoplasmic reticulum-localized glycerol-3-phosphate acyltransferase that catalyzes the first committed step of de novo glycerolipid synthesis, generating lysophosphatidic acid (LPA) from glycerol-3-phosphate and acyl-CoA, thereby channeling exogenous fatty acids into triacylglycerol and away from β-oxidation [PMID:18238778, PMID:18192653, PMID:25918168]. Its enzymatic activity is stimulated by the N-myristoylated binding partner CHP1, enhanced by insulin-dependent phosphorylation via PI3K, and transcriptionally controlled by PPARγ and FXR [PMID:30846317, PMID:20181984, PMID:36398416, PMID:41530783]. GPAT4 is required for lipid droplet biogenesis and milk fat synthesis in mammary epithelium, and in brown adipose tissue it accounts for ~65% of total GPAT activity, limiting exogenous fatty acid oxidation [PMID:16449762, PMID:25918168]. Loss of GPAT4 in endocardial cells triggers ER stress, mitochondrial DNA escape, and cGAS-STING-dependent type-I interferon signaling that causes cardiac developmental defects—a phenotype rescued by ablation of the cGAS-STING pathway [PMID:40199910].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Establishing that AGPAT6/GPAT4 localizes to the ER and is essential for lipid droplet formation and triacylglycerol production resolved its basic cellular function and tissue requirement, as Agpat6-/- mice showed dramatic loss of milk fat and lipid droplets in mammary epithelium.\",\n      \"evidence\": \"Gene-trap knockout mouse, histology, subcellular localization, milk lipid analysis\",\n      \"pmids\": [\"16449762\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enzymatic activity of the protein had not been directly measured\", \"Whether the enzyme acted as a GPAT or AGPAT was unresolved\", \"Mechanism of lipid droplet loss was unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrating that purified AGPAT6 possesses GPAT but not AGPAT activity reclassified the enzyme as GPAT4 and established it as the major NEM-sensitive microsomal GPAT, resolving a long-standing misannotation.\",\n      \"evidence\": \"Purified protein GPAT activity assay, substrate specificity studies, 13C-oleic acid labeling/MS, KO tissue enzyme assays in two independent labs\",\n      \"pmids\": [\"18238778\", \"18192653\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Post-translational regulation of GPAT4 activity was unknown\", \"Substrate selectivity among different acyl-CoA chains was not fully defined\", \"How GPAT4-generated lipid intermediates differed from GPAT1-derived pools remained unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery that insulin stimulates GPAT4 phosphorylation in a PI3K-dependent manner, increasing its activity, connected glycerolipid biosynthesis to anabolic hormone signaling, while showing GPAT4 plays a modest role in adipocyte differentiation relative to GPAT3.\",\n      \"evidence\": \"Insulin stimulation of GPAT4-overexpressing cells, wortmannin inhibition, shRNA knockdown in 3T3-L1 adipocytes\",\n      \"pmids\": [\"20181984\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific phosphorylation sites mediating activation were not mapped\", \"Kinase(s) directly phosphorylating GPAT4 were not identified\", \"Physiological consequence of insulin-driven GPAT4 activation in vivo was not tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Establishing that GPAT4 channels exogenous—but not de novo synthesized—fatty acids into TAG clarified the division of labor between GPAT1 and GPAT4, showing they access distinct fatty acid pools.\",\n      \"evidence\": \"Primary hepatocytes from Gpat1-/- and Gpat4-/- mice, de novo FA synthesis labeling, exogenous [14C]FA incorporation\",\n      \"pmids\": [\"23908354\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis for selective access to exogenous vs. de novo fatty acid pools was unknown\", \"Whether this selectivity applies in non-hepatic tissues was not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Quantifying GPAT4 as ~65% of total GPAT activity in brown adipose tissue and showing that its loss redirects exogenous fatty acids from TAG synthesis into β-oxidation defined GPAT4 as a metabolic gatekeeper in thermogenic fat.\",\n      \"evidence\": \"Gpat4-/- mice, GPAT activity in BAT, differentiated primary brown adipocytes, fatty acid oxidation/incorporation assays\",\n      \"pmids\": [\"25918168\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether increased β-oxidation in GPAT4-null BAT affects whole-body thermogenesis was not conclusively shown\", \"Compensatory changes in GPAT1 or GPAT3 expression were not fully addressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of N-myristoylated CHP1 as a direct binding partner and activator of GPAT4 revealed the first protein-level regulatory mechanism for microsomal GPAT activity.\",\n      \"evidence\": \"CRISPR genetic screens, lipidomics, CHP1-GPAT4 binding assay, N-myristoylation mutagenesis in mammalian cells and invertebrates\",\n      \"pmids\": [\"30846317\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for CHP1-GPAT4 interaction was not resolved\", \"Whether CHP1 regulation is modulated by calcium or other signals was not determined\", \"Tissue-specific importance of CHP1-GPAT4 axis was unexplored\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showing that GPAT4-generated saturated LPAs accumulate at ER-mitochondria contact sites and block autophagosome maturation linked GPAT4 lipid products to autophagy regulation beyond simple TAG storage.\",\n      \"evidence\": \"SCD-knockout VSMCs, lipid metabolite analysis, GPAT4 co-localization with omegasome markers, autophagic flux assays\",\n      \"pmids\": [\"32408172\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct manipulation of GPAT4 (rather than SCD) to confirm the autophagy phenotype was not performed\", \"Whether saturated LPA effects on autophagy are generalizable beyond VSMCs was untested\", \"Physical mechanism by which saturated LPAs block omegasome resolution was not defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identifying PPARγ/RXRα as a transcriptional activator of GPAT4 and linking GPAT4-produced PA to mTORC1 activation established a signaling axis from nuclear receptor to lipid intermediate to nutrient sensing in mammary epithelial cells.\",\n      \"evidence\": \"Promoter-luciferase reporter assay with deletions/mutations, PA rescue, mTORC1 phosphorylation readouts in dairy cow mammary epithelial cells\",\n      \"pmids\": [\"36398416\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PPARγ regulation of GPAT4 occurs in non-mammary tissues was not tested\", \"ChIP confirmation of PPARγ occupancy at the endogenous promoter was lacking\", \"Whether PA-mediated mTORC1 activation is GPAT4-specific or shared with other GPATs was unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrating that GPAT4 loss in endocardial cells triggers ER stress, mitochondrial DNA escape via enhanced ER-mitochondria contacts, and a cGAS-STING-interferon inflammatory cascade causing cardiac defects—rescued by cGAS-STING ablation—established GPAT4 as an ER homeostasis factor whose absence activates innate immune pathways during development.\",\n      \"evidence\": \"Global and endocardial-specific Gpat4 KO mice, ER stress markers, MAM communication assays, mtDNA escape measurement, genetic epistasis rescue via cGAS-STING ablation\",\n      \"pmids\": [\"40199910\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ER stress from GPAT4 loss is due to lipid composition change or protein misfolding was not distinguished\", \"Whether the cGAS-STING pathway is activated in other GPAT4-deficient tissues was not examined\", \"Human genetic evidence linking GPAT4 mutations to congenital heart disease is lacking\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identifying FXR as a transcriptional repressor of GPAT4 and showing that GPAT4 upregulation drives hepatic lipid droplet accumulation in MAFLD models established a second nuclear receptor axis controlling GPAT4 expression with disease relevance.\",\n      \"evidence\": \"siRNA knockdown, dual-luciferase reporter assay, HFD mouse model, in vitro hepatocyte model\",\n      \"pmids\": [\"41530783\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct FXR binding site on the GPAT4 promoter was not mapped by ChIP\", \"Whether FXR-GPAT4 axis operates independently of PPARγ regulation was not addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of GPAT4 catalysis and CHP1 activation, the mechanism by which GPAT4 selectively accesses exogenous versus de novo fatty acid pools, whether GPAT4 mutations cause human disease, and the in vivo significance of GPAT4 nano-confinement on lipid droplet surfaces.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure of GPAT4\", \"No human Mendelian disease linked to GPAT4 mutations\", \"Molecular basis for selective fatty acid pool access is unknown\", \"Functional consequence of LD surface nano-confinement is untested in vivo\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\n        \"term_id\": \"GO:0016740\",\n        \"supporting_discovery_ids\": [0, 1, 6, 7]\n      },\n      {\n        \"term_id\": \"GO:0008289\",\n        \"supporting_discovery_ids\": [0, 5, 6]\n      }\n    ],\n    \"localization\": [\n      {\n        \"term_id\": \"GO:0005783\",\n        \"supporting_discovery_ids\": [0, 2, 7, 10]\n      },\n      {\n        \"term_id\": \"GO:0005811\",\n        \"supporting_discovery_ids\": [2, 11]\n      }\n    ],\n    \"pathway\": [\n      {\n        \"term_id\": \"R-HSA-1430728\",\n        \"supporting_discovery_ids\": [0, 1, 2, 5, 6, 9]\n      },\n      {\n        \"term_id\": \"R-HSA-9612973\",\n        \"supporting_discovery_ids\": [8, 13]\n      },\n      {\n        \"term_id\": \"R-HSA-162582\",\n        \"supporting_discovery_ids\": [3, 9, 10]\n      },\n      {\n        \"term_id\": \"R-HSA-168256\",\n        \"supporting_discovery_ids\": [10]\n      }\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CHP1\",\n      \"BSCL2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}